Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolevulinic acid 20% versus two stage topical methylaminolevulinic acid: Results of a randomized controlled trial
British Journal of Dermatology Sep 13, 2017
Kessels JPHM, et al. - This research analyzed the superiority of 2-fold 5-aminolevulinic acid (ALA)-photodynamic therapy (PDT) compared to conventional methyl-ester (MAL)-PDT for superficial basal cell carcinoma (sBCC). This approach displayed fewer recurrences, despite the lack of prominent variation between both the treatment groups. It, however, led to higher pain scores and more post-treatment side-effects compared to MAL-PDT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries